Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Herpesvirus 2, Human”

115 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 115 results

Early research (Phase 1)Study completedNCT00891137
What this trial is testing

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

Who this might be right for
LeukemiaLymphomaMultiple Myeloma+2 more
Cellerant Therapeutics 30
Testing effectiveness (Phase 2)Study completedNCT01667341
What this trial is testing

Safety and Immunogenicity Study of Therapeutic HSV-2 Vaccine

Who this might be right for
Genital Herpes Simplex Type 2
Genocea Biosciences, Inc. 143
Not applicableStudy completedNCT01112956
What this trial is testing

Serologic Assays for the Diagnosis of Herpes Simplex Virus Type 2

Who this might be right for
Genital Herpes
Centers for Disease Control and Prevention 2,500
Post-approval studies (Phase 4)Not Yet RecruitingNCT05452928
What this trial is testing

Aciclovir Versus Placebo for HSV-2 Meningitis

Who this might be right for
Herpes Simplex 2Meningitis, Viral
Jacob Bodilsen 150
Early research (Phase 1)Study completedNCT00331032
What this trial is testing

VivaGel™ in Healthy Young Women

Who this might be right for
Herpes Simplex II
National Institute of Allergy and Infectious Diseases (NIAID) 56
Not applicableEnded earlyNCT00138320
What this trial is testing

Herpevac Neonatal Substudy

Who this might be right for
Herpes Simplex
National Institute of Allergy and Infectious Diseases (NIAID) 6
Large-scale testing (Phase 3)Study completedNCT00194519
What this trial is testing

Herpes Simplex Virus Type 2 (HSV-2) Suppression to Prevent HIV Transmission

Who this might be right for
HIV InfectionHerpes Simplex, GenitalSexually Transmitted Diseases
University of Washington 3,408
Testing effectiveness (Phase 2)Ended earlyNCT05703607
What this trial is testing

Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults

Who this might be right for
ShinglesHerpes Zoster InfectionHuman
Pfizer 484
Post-approval studies (Phase 4)Study completedNCT00464542
What this trial is testing

Asymptomatic Bacterial Vaginosis and Herpes Simplex Virus Type 2 (BV/HSV-2) Shedding Study

Who this might be right for
Bacterial Vaginosis
University of Pittsburgh 12
Testing effectiveness (Phase 2)Study completedNCT02515175
What this trial is testing

Evaluating New Formulation of Therapeutic HSV-2 Vaccine

Who this might be right for
Genital Herpes Simplex Type 2
Genocea Biosciences, Inc. 131
Early research (Phase 1)Study completedNCT05871541
What this trial is testing

A First-in-Human Study to Evaluate JCXH-105, an SrRNA-based Herpes Zoster Vaccine

Who this might be right for
Herpes Zoster (HZ)ShinglesInfectious Disease
Immorna Biotherapeutics, Inc. 75
Early research (Phase 1)Enrolling By InvitationNCT07330440
What this trial is testing

A Phase I Study to Evaluate the Safety, Tolerability, and Immunogenicity of an mRNA Vaccine Against Herpes Simplex Virus Type 2 (HSV-2) Post-Vaccination

Who this might be right for
Genital Herpes
Changchun BCHT Biotechnology Co. 144
Large-scale testing (Phase 3)Study completedNCT00425984
What this trial is testing

Male Circumcision for HIV Prevention in Rakai, Uganda

Who this might be right for
HIV InfectionsHerpesvirus 2, HumanSyphilis+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 5,000
Early research (Phase 1)Study completedNCT05989672
What this trial is testing

A Study on the Reactogenicity, Safety and Immune Response of a Targeted Immunotherapy Against HSV in Healthy Japanese Participants Aged 18-40 Years

Who this might be right for
Herpes Simplex
GlaxoSmithKline 50
Testing effectiveness (Phase 2)Study completedNCT05089630
What this trial is testing

Safety and Immune Response to Different Doses of a Cytomegalovirus Vaccine in Healthy Adults

Who this might be right for
Cytomegalovirus Infections
GlaxoSmithKline 339
Large-scale testing (Phase 3)Study completedNCT02570126
What this trial is testing

A Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age.

Who this might be right for
Chicken-pox Illness (Varicella Virus Disease)Chickenpox
GlaxoSmithKline 1,236
Early research (Phase 1)Study completedNCT01453075
What this trial is testing

Evaluating Three Grams Daily Valacyclovir in Patients With Chronic Hepatitis C and HSV-2 Infection (Phase I)

Who this might be right for
Chronic Hepatitis C Infection
VA Office of Research and Development 31
Testing effectiveness (Phase 2)Ended earlyNCT05648006
What this trial is testing

First-line Maintenance of OH2 Injection for Advanced Colorectal Cancer

Who this might be right for
Advanced Colorectal Carcinoma
Binhui Biopharmaceutical Co., Ltd. 7
Post-approval studies (Phase 4)Study completedNCT00161434
What this trial is testing

Valacyclovir to Suppress HSV and HIV Shedding in Coinfected Persons

Who this might be right for
Herpes SimplexHIV Infections
University of Washington 60
Not applicableEnded earlyNCT00904514
What this trial is testing

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 241
Load More Results